New drug shows promise for painful skin condition
NCT ID NCT05216224
First seen Jan 11, 2026 · Last updated May 05, 2026 · Updated 17 times
Summary
This study tested an experimental drug called ATI-450 in 95 people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. Participants received either ATI-450 or a placebo for 12 weeks. The main goal was to see if the drug reduced the number of inflamed nodules and abscesses compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aclaris Investigational Site
Birmingham, Alabama, 35244, United States
-
Aclaris Investigational Site
Fort Smith, Arkansas, 72916, United States
-
Aclaris Investigational Site
Encino, California, 91436, United States
-
Aclaris Investigational Site
San Francisco, California, 94115, United States
-
Aclaris Investigational Site
Thousand Oaks, California, 91436, United States
-
Aclaris Investigational Site
Boca Raton, Florida, 33486, United States
-
Aclaris Investigational Site
Hollywood, Florida, 33021, United States
-
Aclaris Investigational Site
Tampa, Florida, 33613, United States
-
Aclaris Investigational Site
Marietta, Georgia, 30060, United States
-
Aclaris Investigational Site
Sandy Springs, Georgia, 30328, United States
-
Aclaris Investigational Site
Metairie, Louisiana, 70006, United States
-
Aclaris Investigational Site
Fort Gratiot, Michigan, 48059, United States
-
Aclaris Investigational Site
Charlotte, North Carolina, 28277, United States
-
Aclaris Investigational Site
Athens, Ohio, 45701, United States
-
Aclaris Investigational Site
Mason, Ohio, 45040, United States
-
Aclaris Investigational Site
Hershey, Pennsylvania, 17033, United States
-
Aclaris Investigational Site
Anderson, South Carolina, 29621, United States
-
Aclaris Investigational Site
Nashville, Tennessee, 37215, United States
-
Aclaris Investigational Site
Houston, Texas, 77054, United States
-
Aclaris Investigational Site
Sugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.